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ABSTRACT
Some Co(II), Cu(II), Ni(II) and Zn(II) complexes of antibacterial drug cephradine have been prepared and
characterized by their physical, spectral and analytical data. Cephradine acts as bidentate and the complexes
have compositions, [M(L)2X2] where [M=Co(II), Ni(II) and Zn(II), L=cephradine and X=CI2] showing
octahedral geometry, and [M(L)2] where [M=Cu(II), L=cephradine] showing square planar geometry. In
order to evaluate the effect of metal ions upon chelation, eephradine and its complexes have been screened
for their antibacterial activity against bacterial strains, Escherichia coli, Staphylococcus aureus, and
Pseudomonas aeruginosa
INTRODUCTION
Evidences supporting the introduction of metallic elements in several biological processes are rapidly
accumulatingr6. Schubert
7 and Kirschner
8 have investigated the antibacterial, antiviral and anticancer
activities of more than 25 inorganic compounds, which included the metal atom as potentially significant part
of the molecule. They suggested8’9 that the transfer of metal ion from the ligand to the cancer-associated
viruses was a mechanism for releasing the anticancer drug in the locality of the tumor. Due to the significant
nature of the metallic ions, their metal complexes are now, being included in the search for ideal anticancer
drugs. Such significant examples of which are, palladium and platinum complexes of 6-mercaptopurine that
destroy
1 adenocarcinomas and similarly, the complexes of dialkyldithiophosphate which reduce some
tumors1. A wide range of activities of even the simplest complexes of metallic elements has been reviewed
by Rosenberg
2 who noticed that the viral-induced cancers all respond to the treatment with even the simplest
metal-amine halide complexes. It has also been demonstrated that ehelation/complexation tend to make
inactive substances/ligands active and active compounds/drugs become more active and less toxic316. All
these evidences however, highlight the need to study and evaluate more the biological applications of
metallic elements for therapeutic potentials.
Cephradine is a first-generation eephalosporin class of antibiotic7, actively used against Gram-positive cocci,
and Gram-negative bacilli. It has similar structural and antibacterial relationship to that of its closely related
analogue cephalexin. It contains the (NH), (COOH), (NH) and (C=O) functional groups and its molecular
model reveals that its structure is suitable for chelation/complexation. A detailed biological evaluation of the
copper(II) and Zn(II) complexes of cephalexin has been reported. In order to evaluate the biological
comparison of both the analogues, we, therefore, report in this paper the preparation, characterization and
biological properties of cobalt(II), copper(II), niekel(II) and Zn(II) complexes of eephradine which may be an
addition to reveal the significance of the strong relationship between metals, or their complexes, and
bactericidal activity.
EXPERIMENTAL
Material and Methods
All chemicals and solvents used were of Analar grade. All metal(II) salts were used as chlorides. Sodium salt
of cephradine was obtained by reacting equimolar amount of sodium hydroxide with cephradine. IR spectra
were recorded on a Philips Analytical PU 9800 FTIR spectrophotometer as KBr discs. UV-Visible spectra
were obtained in DMF on a Hitachi U-2000 double-beam spectrophotometer. C, H and N analyses was
carried out by Butterworth Laboratories Ltd. Conductance of the metal complexes was determined in DMF
on a Hitachi YSI-32 model conductometer. Magnetic measurements were made on solid complexes using the
Gouy method. Melting points were recorded on a Gallenkamp apparatus and are uncorrected.
Preparation of cobalt(ll)-cephrafline Complex
An ethanol solution (20 mL) of the cobalt chloride hexahydrate (0.24 g, 0.001 M) was added to a
magnetically stirred sodium salt of cephradine (0.8 g, 0.002 M) in distilled water (25 mL). The mixture was
refluxed for h and cooled to room temperature. On cooling, pink precipitates were formed, filtered and
washed with ethanol, acetone and ether, and dried by suction. Crystallization in aqueous ethanol (70 30)
gave the desired metal complex. All other metal complexes were formed following the same method.
Antibacterial Studies
The synthesized metal complexes, in comparison to the uncomplexed cephradine were screened for their
antibacterial activity against pathogenic bacterial species, Escherichia coli, Staphylococcus aureus and
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Pseudomonas aeruginosa. The paper disc diffusion method was adopted for the determination of
antibacterial activity"r4"16.
RESULTS AND DISCUSSION
All the complexes are intensely colored and stable amorphous solids, which did not have sharp melting
points and decompose above 225C. The complexes are only soluble in DMF and DMSO and insoluble in all
other common organic solvents. Their melting behavior, solubility and crystalline nature suggest that they are
monomers. Molar conductance values (14-18 ohmlcmZmol"l) of the complexes in DMF solution indicated
19
that all ofthe complexes are non-electrolytes.
Table 1.
Cephradine
Physical and Analytical Data ofthe Metal(!I) Complexes
Comple M.p B.M.
Mol. Formula (C) (laar)
218
232-234 4.7
228’230 1.4
231-233 3.3
234’236 Dia
(1) [Co(L)2(C1)2] C32H36CoCI2N6OsS2 [956.9]
[Cu(L)2] C32H36CuN608S2 [890,7]
[Ni(L)2(CI)2] C32H36NiClN608S [95617]
[Zn(L):z(CI)2] C32H36ZnCIN608S2 [963.4]
Yield
(%)
60
62
58
62
cale. (Found) %
C H N CI
40.1 3.8 8.8 7.4
(39.9)(3.5)(8.9)(7.2)
43.1 4.0 9.4
(43.4)(3.9)(9.7)
40.1 3.8 8.8 7.4
(40.5)(4.1)(8.6)(7.3)
39.8 3.7 8.7 7.3
(40,!)(3.5)(8.9)(7.5)
Examination of the physical model of cephradine shows that it can exhibit either ONON, OONO or OOON
donor quadridentate, ONO, OOO, NNO or NNN donor tridentate and NO, OO, or NN donor bidentate
behavior. The molecular model studies further reveal that in no cases the ligand can stereochemically behave
as quadridentate or tridentate.
The IR spectra of the complexes in comparison to the uncomplexed cephradine are listed in Table 2 with
some tentative important characteristic assignments2. The IR spectrum of the cephradine shows some
characteristic bands at 3345, 3240, 1770 and 1745 mainly due to the v(NH2), v(NH), v(COOH) and v(C=O)
vibrations, respectively. The metal complexes contained all the bands from cephradine and also other bands
indicative of the coordination of the ligand with the metal ions. The band due to v(COO)asym at 1770 cm" in
the spectrum of the ligand shifted to lower frequency (10-15 cm") in all the metal complexes indicative of
the complexation2. A new absorption band instead, assigned to v(COO) and v(M-O) appeared at 1565-1575
and 450-455 cm
"1 which were only observed in the spectra of the complexes. This in turn, indicated that the
carboxyl group is coordinated to the metal ion. Also, the band due to v(NH2) at 3345 cm" was found shifted
to lower wave number (15-20 cm"l) in the spectra of its metal complexes. And a new band at 415-420 cm
-l
assigned to v(M-N) was evolved in the spectra of the complexes indicating
2 involvement of the v(NH)
group via nitrogen in the coordination. Moreover, In the far infrared region a new band at 335 cm
1 was found
in the spectra of the Co(II), Ni(lI) and Zn(II) complexes and not observed in the spectrum of the Cu(II)
complex assigned to v(M-CI) modes respectively. It in turn, indicated that two chloride atoms are also
coordinated to the metal atom. These evidences however, indicated that the Co(II) Ni(II) and Zn(II)
complexes possess an octahedral geometry (Fig 1A) and Cu(II) complex to show square planar geometry
H and lC NMR spectra of the uncomplexed cephradine and its metal complexes have been recorded in
DMSO-d6 with TMS as internal reference and are summerized in Table 2 with some tentative assignments.
The spectra of cephradine exhibited peaks as expectedza. Signals for the NH and COOH protons in the
spectra of uncomplexed Cephradine at 1.1 and 10.8 ppm disappeared in the complexes. This indicated that
Cephradine is coordinated to the metal ions by deprotonation. In the complexes the aromatic proton signals
24 25 appeared downfield due to increased conjugation during coordination
UV-Visible spectral bands of the complexes are recorded in Table 2. The cobalt(II) complex shows magnetic
moment 4.7 B.M. at room temperature (Table. 1). These high value of the magnetic moment and the
stoichiometry suggest a coordination number of six for the central cobalt(II) ion and an octahedral geometry.
The electronic spectrum of the complex is consistent with its octahedral environment around the cobalt(II)
ion (Fig.lA). The spectrum displays two bands at 20,715 and 28,580 cm
"1 attributed to 4Tlg 4Tlg and 4Tlg
4 26 27 T2g transitions, respectively, in a high-spin octahedral geometry
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Table 2. IR, UV andNMR Spec
Cephra
dine/
Complex,.
Cephra
dine
3345 (s, NHz), 3240
(ms, NH), 1770 (s,
COOH), 1745 (s,
c=o)
3530 (s, NH2),1760,
1565 (s, COO), 450
(m, M-N), 420 (m,
M-O), 355 (m, M-
Cl)
3535 (s, NH2),1755,
1565 (s, COO), 455
(m, M-N), 425 (m,
M-O)
3535 (s, NH2), 1762,
1570 (s, COO), 455
(m, M-N), 425 (m,
M-O), 355 (m, M-
CI)
3533 (s, NH2),1760,
1565 (s, CO0), 450
(m, M-N), 422 (m,
M-O), 355 (m, M-
Cl)
Xoscopic Data ofthe Metal(II) Complexes
(cn.a,t)
IH-NMR (DMSO-d6)
(ppm)
20715,
2850
15155,
18575,
30245
16570,
27375
27555
s=sharp, ms=medium sharp, m=medium
2.3 (s, 6H, CH3), 4.5 (d, 2H,
NCH), 7.1 (m, 4H, Ph), 7.2 (m,
4H, Ph), 7.4 (m, 2H, Ph), 8.1 (d,
2H, i-Lactam), 8.3 (m, 4H,
hetero-Ph), 8.4 (m, 2H, hetero-
Ph).
2.3 (s, 6H, CH3), 4.5 (d, 2H,
NCH), 7.1 (m, 4H, Ph), 7.2 (m,
4H, Ph), 7.4 (m, 2H, ah), 8.1 (d,
2H, -Lactam), 8.3 (m, 4H,
hetero-Ph), 8.4 (m, 2H, hetero-
Ph).
2.3 (s, 6H, CH3), 4.5 (d, 2H,
NCH), 7.1 (m, 4H, Ph), 7.2 (m,
4H, Ph), 7.4 (m, 2H, Ph), 8.1 (d,
2H, I-Lactam), 8.3 (m, 4H,
hetero-Ph), 8.4 (m, 2H, hetero-
Ph).
2.3 (s, 6H, CH3), 4.5 (d, 2H,
NCH), 7.1 (m, 4H, Ph), 7.2 (m,
4H, ah), 7.4 (m, 2H, Ph), 8.1 (d,
2H, i-Lactam), 8.3 (m, 4H,
hetero-Ph), 8.4 (m, 2H, hetero-
Ph).
2.3 (s, 6H, CH3), 4.5 (d, 2H,
NCH), 7.1 (m, 4H, Ph), 7.2 (m,
4H, Ph), 7.4 (m, 2H, Ph), 8.1 (d,
2H, I$-Lactam), 8.3 (m, 4H,
hetero-Ph), 8.4 (m, 2H, hetero-
Ph).
C-NMR (DMSO-d6)
(ppm)
13 (CH3), 63 (CHN), 117
(-Lactam), 120, 122, 124
(hetero-Ph), 148, 125,
127, 128, 172 (C=O), 177
(COO), 212 (l-Lactam).
13 (CH3), 63 (CHN), 117
(l-Lactam), 120, 122, 124
(hetero-Ph), 148, 125,
127, 128, 172 (C=O), 177
(COO), 212 (i5-Lactam).
13 (CH3), 63 (CHN), 117
(l$-Lactam), 120, 122, 124
(hetero-Ph), 148, 125,
127, 128, 172 (C=O), 177
(COO), 212 (I5-Lactam).
13 (CH3), 63 (CHN),’ 117
(l$-Lactam), 120, 122, 124
(hetero-Ph), 148, 125,
127, 128, 172 (C=O), 177
(COO), 212 (13-Lactam).
13 (CH3), 63 (CHN), 117
(-Lactam), 120, 122, 124
(hetero-Ph), 148, 125,
127, 128, 172 (C=O), 177
(COO), 212 (l-Lactam).
[IA] M=Co(II), Ni(II) or Zn(II); X=CI
[1B] M=Cu(II); X=O
Fig. 1. Proposed Structure for the Metal(II).Complexes
The Cu(II) complex shows two weak low-energy bands at 15,155 cm and 18575 cm and a strong high-
energy band at 30,245 cm". The low-energy bands are in positions typically found for square planar
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configuration and may be assigned to 2Big -
2Alg and 2Big --
2Eg transitions respectively2s’29. The strong
high-energy band is assigned to metal ---
ligand charge transfer. Also, the magnetic moment value (1.4 B.M)
for the Cu(II) complex is found to be consistent with the proposed square planar geometry (Fig 1B) for the
Cu(II) complex.
The electronic spectra of the nickel(II) complex exhibited absorption bands at 16,570 and 27,375 cm,
attributed to 3A2g 3Tlg (F) and 3AEg 3Tlg (P) transitions, respectively, in an octahedral geometry3’3. The
calculated values of the ligand field parameter lie in the range reported for an octahedral structure. Also, the
value ofthe magnetic moment (3.3 B.M.) may be taken as an additional evidence for its octahedral structure.
The diamagnetic zinc(II) complex did not show any d-d bands and its spectrum is dominated only by_ the
charge transfer band. This charge transfer band at 27,555 cm was assigned to the transition 2Eg ---, 2T2g,
possibly in an octahedral environment3.
On the basis of the above observations, it is tentatively suggested that the Co(II), Ni(II) and Zn(II) complexes
show an octahedral geometry (Fig. 1A) in which the two cephradine molecules act as bidentate and at axial
positions two chlorides are coordinated to the metal atom. In the Cu(II) complex the two cephradine
molecules respectively, acting as bidentate show a square planar geometry of the complex (Fig. 1B) by
possibly accommodating themselves around the metal atom in such a way that a stable chelate ring is formed.
Antibacterial Properties
Cephradine in comparison to its metal(II) chelates was evaluated for antibacterial activity against the
standard bacterial strains, Escherichia coli (a),), Staphylococcus aureus (b) and Pseudomonas aeruginosa (c)
The compounds were tested at a concentration of 30 lag/0.01 mL in DMF solution using the paper disc
diffusion method reported33’34 as earlier. The susceptibility zones were measured in diameter (mm) and the
results are reproduced in Table 3. The susceptibility zones were the clear zones around the discs. Cephradine
and its complexes individually were found to be biologically active showing various degrees of inhibitory
effects on the growth of the tested bacterial species. The antibacterial results evidently show that the
complexation improved the antibacterial activity. These observations however, suggest that the metallic
elements should be seriously considered in <drug designing>. Their use could provide an easy way of
improving the bactericidal activity ofmany drugs/antibacterial agents.
Table 3. Antibacterial Activity Data ofCephradine and its Metal(II) Complexes
Cephradine/Complex M c r o b a S p e c e s
a b c
Cephradine ++ + ++
(1) +++ ++ +++..
(2) ++++ +++ +++
(3) +++ ++ ++++
(4) +++ +++ ++
a Escherichia coli, b Staphylococcus aureus,
c Pseudomonas aeruginosa. Inhibition zone diametermm (% inhibition): +, 6-10 (27-45 %);
++, 10-14 (45-64 %); +++, 14-18 (64-82 %); ++++, 18-22 (82-100 %). Percent inhibition values
are relative to inhibition zone (22 mm) with O0 % inhibition.
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